A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

Clinical trial NCT03829254 · RECRUITING

Trial details

NCT number: NCT03829254
Sponsor: NuCana plc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Lymphoma Solid Tumor Melanoma

Start date: 2019-06-17
Primary completion: 2026-08-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.